How to Get Enclomiphene Citrate in Tennessee

What Is Enclomiphene Citrate and Why Is It Used?

Enclomiphene is the trans-isomer of clomiphene and works by blocking estrogen receptors at the hypothalamus, which prompts the pituitary to release more LH and FSH, which in turn stimulates testicular testosterone production. It raises serum testosterone while preserving sperm production, a profile that distinguishes it from exogenous testosterone therapy. Kim et al. (BJU Int, 2016, N=124) found enclomiphene 12.5 mg and 25 mg daily restored testosterone to normal range in men with secondary hypogonadism while maintaining sperm concentrations above baseline, outcomes that injectable testosterone did not match on the fertility endpoint [1].

The drug's mechanism is addressed in the Endocrine Society's 2018 clinical practice guideline on male hypogonadism, which states: "In men with hypogonadotropic hypogonadism who wish to maintain fertility, gonadotropin or clomiphene-based therapy is preferred over testosterone replacement." [2] Enclomiphene, as the more receptor-selective isomer, fits squarely within that recommendation even though it lacks a final FDA approval for commercial sale as a finished drug product.

Because no manufacturer holds an approved new drug application for an enclomiphene finished-dose product, U.S. patients currently obtain the drug through 503A compounding pharmacies operating under FDA oversight of bulk drug substances. The FDA's bulk drug substance list and compounding framework govern which substances pharmacies may prepare [3]. Tennessee-licensed 503A pharmacies may legally compound and dispense enclomiphene to individual patients with a valid patient-specific prescription.

A 2020 study in the Journal of Urology (Wiehle et al., N=188) reported that men receiving enclomiphene 12.5 mg daily for 6 months achieved mean total testosterone of 498 ng/dL versus 275 ng/dL at baseline, a statistically significant increase (P<0.001) [4]. Serum LH and FSH rose proportionally, confirming the central mechanism of action rather than peripheral suppression [4].

Is Enclomiphene Legal and Available in Tennessee?

Enclomiphene is legal to prescribe and dispense in Tennessee. State law permits any licensed prescriber to write for compounded preparations when a commercial equivalent is not available, and enclomiphene meets that criterion. Tennessee Code Annotated Title 63 governs prescribing authority; telehealth prescribing is explicitly permitted under TCA 63-1-155, provided the prescriber establishes a valid patient-provider relationship before ordering a controlled or non-controlled medication [5].

Enclomiphene is not a scheduled controlled substance under either federal DEA scheduling or Tennessee state scheduling. That means prescribers may transmit the prescription electronically, by phone, or on paper without the additional requirements that apply to Schedule II and III drugs.

Tennessee Medicaid (TennCare) does not cover enclomiphene for secondary hypogonadism. Coverage is only available for FDA-approved indications in specific disease states. Cash-pay pricing through 503A compounding pharmacies in Tennessee ranges from approximately $60 to $150 per 30-day supply depending on dose and pharmacy, though prices vary and patients should confirm directly with the dispensing pharmacy.

The FDA's position on compounded enclomiphene has shifted over time. In 2022, the agency removed enclomiphene from its list of bulk drug substances that may be used in compounding under Section 503A, citing the existence of an investigational new drug application. Compounders challenged that removal, and subsequent agency communications have clarified the current permissible status. Patients and prescribers should verify current compounding status with the dispensing pharmacy at the time of prescribing, because the regulatory picture may change [3].

Who Can Prescribe Enclomiphene Citrate in Tennessee?

Any Tennessee-licensed prescriber with authority to write for non-controlled compounds may prescribe enclomiphene. That includes MDs, DOs, nurse practitioners holding full prescriptive authority (APRN-CNP or APRN-CNS with a collaborative practice agreement or independent authority under Tennessee's 2023 APRN reforms), and physician assistants with a supervision agreement allowing Schedule VI and non-scheduled drugs.

Tennessee granted APRNs with at least 3 years and 9 to 000 hours of supervised practice the ability to apply for independent prescriptive authority beginning in 2023 under SB 0739. This change expanded the pool of telehealth providers who can legally prescribe enclomiphene without a supervising physician co-signing each order [5].

Urologists, endocrinologists, and men's health-focused primary care physicians are the most common prescribers in clinical practice. A 2021 AUA guideline update on testosterone deficiency specifically recognizes that "selective estrogen receptor modulators such as clomiphene citrate are viable options for men with secondary hypogonadism, particularly those desiring preservation of fertility." [6] That guideline supports the practice of off-label SERM prescribing by urologists and other specialists.

Telehealth platforms operating in Tennessee can connect patients with licensed Tennessee providers. The provider must be licensed in Tennessee (or hold a Tennessee telehealth registration) and must use a HIPAA-compliant platform. A same-day audio-video visit satisfies the patient-provider relationship requirement for non-controlled prescriptions under Tennessee law [5].

What Labs Are Required Before Getting a Prescription?

Baseline lab work is required before any responsible prescriber writes for enclomiphene. The minimum panel includes total testosterone (drawn before 10 a.m. on two separate days), LH, FSH, complete blood count, and comprehensive metabolic panel. Many providers also order a lipid panel, estradiol, PSA (for men over 40), and prolactin to rule out a pituitary adenoma as the cause of low LH [2].

The Endocrine Society 2018 guideline specifies that diagnosis of hypogonadism requires "at least two low morning total testosterone measurements." [2] A single low value is insufficient. This two-sample requirement protects patients and prescribers from treating transient suppression caused by acute illness, sleep deprivation, or recent alcohol use.

Reference ranges matter. Most assays flag total testosterone below 300 ng/dL as low, but the clinical threshold for treatment is nuanced. The 2018 guideline states: "We suggest offering testosterone therapy to men with total testosterone concentrations consistently below 264 ng/dL who have symptoms of androgen deficiency." [2] Enclomiphene is most appropriate when LH and FSH are low-normal or low (indicating a central, not primary, deficiency), because the drug works by stimulating the hypothalamic-pituitary axis rather than replacing testosterone directly.

Semen analysis is recommended for men seeking enclomiphene specifically to preserve fertility. Wiehle et al. (2020) documented that sperm concentration remained stable or improved in men on enclomiphene 12.5 mg daily for 6 months, while comparable men on topical testosterone gel saw sperm concentration fall to near-azoospermic levels [4].

Follow-up labs at 6 to 8 weeks confirm response. A testosterone that remains below 300 ng/dL after 6 weeks at 12.5 mg may prompt a dose adjustment to 25 mg. Annual monitoring of hematocrit, testosterone, LH, and PSA is standard practice [2].

How to Get Enclomiphene Through Telehealth in Tennessee

Telehealth is the most efficient access pathway for most Tennessee residents. The state's telehealth statute permits full prescribing for non-controlled substances after a synchronous audio-video encounter. The process follows four steps.

Step 1: Schedule a telehealth consult. Choose a platform or individual provider licensed in Tennessee. Confirm the provider prescribes enclomiphene specifically, because not every men's health telehealth service does. HealthRX connects patients with board-certified physicians who assess and prescribe for secondary hypogonadism in Tennessee.

Step 2: Complete intake forms and upload labs. Most platforms send a health history questionnaire before the visit. If you already have recent testosterone panels (drawn within 90 days), upload them. If not, many telehealth providers can order labs through LabCorp or Quest Diagnostics with 200-plus draw locations across Tennessee before your appointment.

Step 3: Attend the video visit. The provider reviews symptoms (fatigue, reduced libido, brain fog, decreased morning erections), lab values, and medical history. Contraindications include a testosterone level in the normal range, primary hypogonadism (elevated LH/FSH), untreated hyperprolactinemia, or a personal history of thromboembolic events [2].

Step 4: Prescription sent to a 503A pharmacy. If enclomiphene is appropriate, the provider transmits a patient-specific prescription electronically to a licensed 503A compounding pharmacy. The pharmacy ships directly to your Tennessee address. Ground shipping from most compounders serving Tennessee takes 2 to 5 business days after the prescription is verified.

Total elapsed time from scheduling to receiving the medication is typically 7 to 14 days. Same-day consults followed by next-day lab draws can compress this to under a week for patients who move quickly through each step.

Which Pharmacies Dispense Enclomiphene in Tennessee?

503A compounding pharmacies licensed by the Tennessee Board of Pharmacy may prepare and dispense enclomiphene citrate to individual patients with a valid prescription. "503A" refers to Section 503A of the Federal Food, Drug, and Cosmetic Act, which allows state-licensed pharmacies to compound preparations for specific patients rather than for general commercial distribution [3].

Tennessee has dozens of active compounding pharmacies. National compounders with Tennessee licensure and a track record in hormonal compounds include well-known mail-order operations in Florida, Texas, and Colorado that hold Tennessee nonresident pharmacy licenses. Your prescriber or telehealth platform typically partners with one or two preferred compounders who carry enclomiphene in stock and can ship within 24 to 48 hours of receiving the prescription.

Key questions to ask any pharmacy before filling:

• Is enclomiphene currently on your formulary and in stock?
• What is the certificate of analysis for the bulk API, and what third-party lab performed the purity testing?
• What are the capsule or tablet excipients (relevant for patients with gluten or lactose sensitivity)?
• What is the current price per 30 capsules at my prescribed dose?
• Do you ship temperature-controlled, and what is the transit time to Tennessee zip codes?

The FDA periodically inspects 503A compounders and posts warning letters and inspection records publicly [3]. Reviewing a pharmacy's inspection history on the FDA website is a reasonable due-diligence step for any patient.

503B outsourcing facilities, which produce larger batches without patient-specific prescriptions, are generally not the correct source for enclomiphene because the drug is not on FDA's 503B bulks list. Prescriptions should be routed to 503A pharmacies only.

Transferring an Existing Enclomiphene Prescription to Tennessee

Patients relocating to Tennessee who already receive enclomiphene from an out-of-state prescriber face two separate transfer issues: the prescriber relationship and the pharmacy.

On the prescriber side, a provider licensed only in the patient's prior state cannot continue prescribing once the patient establishes Tennessee residency. Tennessee law requires the prescriber to hold a Tennessee license (or a qualifying telehealth registration) at the time of prescribing. The patient needs a new Tennessee-licensed prescriber. A telehealth intake visit with lab upload from prior panels typically satisfies this in a single appointment.

On the pharmacy side, a compounded drug prescription is not transferable between pharmacies the way a commercially manufactured drug prescription is. The new Tennessee-licensed prescriber must send a fresh prescription to the chosen pharmacy. If the prior pharmacy is also licensed in Tennessee as a nonresident compounder, the patient may continue with that pharmacy under the new prescription. If not, the patient selects a Tennessee-licensed compounder.

Bring documentation from prior treatment: dated lab panels, any prior prescriptions, and a summary of doses used and clinical response. This shortens the new intake visit considerably and helps the new provider calibrate starting dose.

Dosing, Side Effects, and Monitoring Once You Start

The standard starting dose is 12.5 mg orally once daily. Some protocols use 25 mg daily from the outset in men with total testosterone persistently below 200 ng/dL. Kim et al. (2016) used both 12.5 mg and 25 mg arms and found both produced statistically significant testosterone increases, with the 25 mg arm yielding modestly higher mean levels but also higher estradiol [1].

Common side effects include mild visual disturbances (reported in roughly 1 to 2 percent of users in SERM trials), mood changes, and, at higher doses, elevated estradiol causing breast tenderness. The visual side effect is a class effect of clomiphene-based compounds mediated by retinal estrogen-receptor binding. Any visual change warrants prompt discontinuation and ophthalmology referral [1].

Estradiol monitoring at 6 to 8 weeks helps identify patients who aromatize aggressively. Men whose estradiol exceeds 40 pg/mL on enclomiphene may require a low-dose aromatase inhibitor (anastrozole 0.5 mg twice weekly is a common adjunct) or a dose reduction. This is managed on an individual basis, not as a standing protocol.

PSA should be checked at baseline and at 3 months in men over 40. The AUA 2021 guideline notes that testosterone-raising therapies may unmask subclinical prostate pathology, and the same caution applies to enclomiphene even though the mechanism differs from exogenous testosterone [6].

Hematocrit elevation (erythrocytosis) is less common with enclomiphene than with injectable testosterone. Testosterone-raising via central stimulation produces a gentler rise in erythropoiesis. Still, a CBC at 6 months is standard. A hematocrit above 54 percent requires dose reduction or temporary cessation per standard androgen-therapy monitoring guidelines [2].

Cost, Insurance, and Prior Authorization in Tennessee

TennCare does not cover enclomiphene for hypogonadism. Commercial insurers in Tennessee rarely cover compounded drugs, and prior authorization for a compounded preparation that lacks an FDA approval for the prescribed indication is almost never granted. Patients should plan for out-of-pocket cost.

Cash-pay pricing at 503A compounders typically runs $60 to $150 per 30-day supply for 12.5 mg to 25 mg capsules. Some telehealth platforms bundle the consult fee and medication cost into a monthly subscription of $100 to $200.

If a Tennessee commercial insurer does request prior authorization documentation, the package typically needs: two morning total testosterone values below the lab's reference range, an LH/FSH confirming secondary (central) etiology, documentation that commercial testosterone products were considered, and a clinical note explaining why fertility preservation or the central-stimulation mechanism makes enclomiphene the preferred agent. The Endocrine Society guideline [2] and Kim et al. (2016) [1] are the two most-cited references in prior authorization appeals for SERM-based hypogonadism therapy.

HSA and FSA funds are generally eligible for prescription medications including compounded preparations. Patients with active HSA or FSA accounts should use those funds to reduce effective out-of-pocket cost.